Fundz

Dianthus Therapeutics, Inc. reported raising $100 Million in an initial SEC Form D filing, from an offering of $100 Million

PRIVATEApr 21, 2022

Amount Raised

$100 Million

$100 Million sold, per SEC Form D (first sale Apr 21, 2022)

Round Type

Venture

WalthamBiotechnology

Quick answer

Dianthus Therapeutics, Inc. raised $100 Million in a funding round, dated April 21, 2022. Dianthus Therapeutics, Inc. is based in Waltham, Massachusetts, United States.

How much did Dianthus Therapeutics, Inc. raise?
Dianthus Therapeutics, Inc. raised $100 Million in a funding round on April 21, 2022.
What does Dianthus Therapeutics, Inc. do?
Dianthus Therapeutics is a clinical-stage biotechnology company dedicated to designing and delivering novel, best-in-class monoclonal antibodies with improved selectivity and potency.
Where is Dianthus Therapeutics, Inc. based and how big is it?
Dianthus Therapeutics, Inc. is based in Waltham, Massachusetts, United States.
Who are the decision-makers at Dianthus Therapeutics, Inc?
Fundz holds 1 contact at Dianthus Therapeutics, Inc. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Biotechnology around the same time

Companies in the same sectors as Dianthus Therapeutics, Inc. that raised within 45 days of this round, from Fundz verified event records.

  • GB SCIENCES raised $25K (Seed) on June 3, 2022.
  • SightStream raised an undisclosed amount on June 3, 2022.
  • RAPT Therapeutics raised $50M on June 3, 2022.
  • Enrich Biosystems raised $3.8M on June 3, 2022.
  • Vizgen raised $85M (Series C) on June 3, 2022.
  • SightStream raised $1.9M (Seed) on June 3, 2022.

Who to call at Dianthus Therapeutics, Inc., and when

A new round usually means Dianthus Therapeutics, Inc. is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Dianthus Therapeutics, Inc. raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Dianthus Therapeutics, Inc., from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Dianthus Therapeutics, Inc.. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Dianthus Therapeutics, Inc.

Location

203 CRESCENT STREET, BLDG #4, STE 205

Waltham, Massachusetts, United States

About

Dianthus Therapeutics is a clinical-stage biotechnology company dedicated to designing and delivering novel, best-in-class monoclonal antibodies with improved selectivity and potency. Based in New York City and Waltham, Mass., Dianthus is comprised of an experienced team of biotech and pharma executives who are leading the development of next-generation antibody complement therapeutics, aiming to deliver transformative medicines for people living with severe autoimmune and inflammatory diseases.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Dianthus Therapeutics, Inc. raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Verified contacts11 people are listed at Dianthus Therapeutics, In…. We don't have their email yet.See plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for Dianthus Therapeutics, Inc.'s next move

See what Strategic adds

Dianthus Therapeutics, Inc. raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.